Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
|---|---|---|---|---|---|---|---|---|---|---|---|
| N2586 | IKK16 | 2.0 | uM | 1 | IL-6 | 4393.0 | 61 | ||||
| N2586 | JNK-IN-8 | 3.0 | uM | 1 | IL-6 | 2856.0 | 63 | ||||
| RA2159 | EGF | 100 | ng/mL | 1 | IL-6 | 9235.0 | 57 | ||||
| RA2159 | PD184352 | 0.1 | uM | EGF | 100 | ng/mL | 1 | IL-6 | 6679.0 | 55 | |
| RA2159 | Lestaurtinib | 0.3 | uM | EGF | 100 | ng/mL | 1 | IL-6 | 4644.0 | 60 | |
| RA2159 | Ruxolitinib | 0.3 | uM | EGF | 100 | ng/mL | 1 | IL-6 | 4786.0 | 61 | |
| RA2159 | Tofacitinib | 0.3 | uM | EGF | 100 | ng/mL | 1 | IL-6 | 7599.0 | 52 | |
| RA2159 | IKK16 | 2.0 | uM | EGF | 100 | ng/mL | 1 | IL-6 | 5572.0 | 48 | |
| RA2159 | JNK-IN-11 | 0.3 | uM | 1 | IL-6 | 3970.0 | 106 | ||||
| N2586 | EGF | 100 | ng/mL | 1 | IL-6 | 7018.0 | 57 | ||||
| N2586 | PD184352 | 0.1 | uM | EGF | 100 | ng/mL | 1 | IL-6 | 5973.5 | 70 | |
| N2586 | Lestaurtinib | 0.3 | uM | EGF | 100 | ng/mL | 1 | IL-6 | 3216.5 | 72 | |
| N2586 | Ruxolitinib | 0.3 | uM | EGF | 100 | ng/mL | 1 | IL-6 | 5776.0 | 45 | |
| N2586 | Tofacitinib | 0.3 | uM | EGF | 100 | ng/mL | 1 | IL-6 | 4323.0 | 66 | |
| N2586 | IKK16 | 2.0 | uM | EGF | 100 | ng/mL | 1 | IL-6 | 5872.0 | 40 | |
| N2586 | JNK-IN-11 | 0.3 | uM | 1 | IL-6 | 5031.5 | 66 | ||||
| RA2159 | IGF-I | 100 | ug/mL | 1 | IL-6 | 6411.5 | 68 | ||||
| RA2159 | PD184352 | 0.1 | uM | IGF-I | 100 | ug/mL | 1 | IL-6 | 4386.0 | 71 | |
| RA2159 | Lestaurtinib | 0.3 | uM | IGF-I | 100 | ug/mL | 1 | IL-6 | 4715.5 | 66 | |
| RA2159 | Ruxolitinib | 0.3 | uM | IGF-I | 100 | ug/mL | 1 | IL-6 | 5956.0 | 81 | |
| RA2159 | Tofacitinib | 0.3 | uM | IGF-I | 100 | ug/mL | 1 | IL-6 | 4873.0 | 89 | |
| RA2159 | IKK16 | 2.0 | uM | IGF-I | 100 | ug/mL | 1 | IL-6 | 4777.0 | 94 | |
| RA2159 | 1 | IL-6 | 6513.0 | 74 | |||||||
| N2586 | IGF-I | 100 | ug/mL | 1 | IL-6 | 5108.0 | 63 | ||||
| N2586 | PD184352 | 0.1 | uM | IGF-I | 100 | ug/mL | 1 | IL-6 | 4484.0 | 68 |